BioEVAL: Tests Real Talents of Artificial Intelligence Models in Bioengineering

Despite the fact that large language models (LLMs) show impressive achievements in the field of medical and biological sciences, current assessment methods remain insufficient to reveal the true potential of these models. Researchers need a more comprehensive approach to measure performance in particularly experimental problem solving and multimodal tasks.

To solve this problem, a group developed a new benchmarking platform named BioEVAL** (BioEngineering Validation of AI and LLMs):

• Current assessments often focus on remembering real knowledge, BioEVAL tests experimental intelligence and problem solving capabilities
• The platform is a multi-disciplinary initiative designed based on actual bioengineering scenarios
• Designed to systematically assess the limits of LLMs and multimodal models
• Frontier offers a comprehensive set of data covering tasks and frontier models

BioEVAL has the potential to create a new standard in assessing applications in medicine and biology of artificial intelligence. The common problem in the field of activity has not been known how the general purpose models perform in specific problems. This benchmark will allow researchers and companies to understand how they treat their models against real-world bioengineering challenges.

The results of the research can draw a clearer picture about the reliability and effectiveness of AI systems in the future. BioEVAL is the purpose of filling this critical cavity by cooperating between academic institutions and industries.